SCHEMBL10129934

SCHEMBL10129934

CC(C)c1nc(N(C)C)nc(-c2ccc(F)cc2)c1CC1CO1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GCGR P47871 11/20 0.38
AKT1 P31749 2/20 0.38
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
HIF1A Q16665 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CYP3A4 P08684 1/20 0.36
PDE6D O43924 1/20 0.36
NR1I2 O75469 1/20 0.36
HMGCR P04035 1/20 0.36
PDE4D Q08499 1/20 0.36
ABCC3 O15438 1/20 0.35
ABCC4 O15439 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875108 0.88 AKT1 (0.38) GCGRAKT1ALDH1A1CYP3A4PDE6D
SCHEMBL698952 0.87 AKT1 (0.51) AKT1ALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL17875114 0.81 ADORA1 (0.41) GCGRHMGCR
SCHEMBL10129522 0.81 GCGR (0.57) GCGRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL20146246 0.80 GCGR (0.43) GCGRAKT1ALDH1A1CYP3A4PDE6D
SCHEMBL10129495 0.80 GCGR (0.43) GCGRAKT1ALDH1A1CYP3A4PDE6D
SCHEMBL20146255 0.78 GCGR (0.41) GCGRAKT1ALDH1A1CYP3A4PDE6D
SCHEMBL10129253 0.77 GCGR (0.45) GCGRAKT1ALDH1A1CYP3A4PDE6D
SCHEMBL10129511 0.77 GCGR (0.37) GCGRALDH1A1CYP1A2CYP2D6CASP1
SCHEMBL10129494 0.75 GCGR (0.46) GCGRALDH1A1CYP1A2CASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012013325-A1 PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF STATINS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF LEK PHARMACEUTICALS D.D. (SI) 2012-02-02 WO disclosed